A28 Therapeutics
PrivateLast Round
Series A
Oct 30, 2023
Total Funding Raised
$1.9M
Company Overview
A28 Therapeutics operates in Healthcare & Life Sciences and is based in La Jolla, California. It has raised $1.9M.
A28 Therapeutics is a biopharmaceutical company developing a targeted oncolytic peptide platform for the treatment of multiple cancer types.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A28 Therapeutics Comparables
Compare A28 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Esperance Pharmaceuticals, Inc. | 88% | |
| Cybrexa Therapeutics | 79% | |
| Shanghai Best-Link Bioscience | 77% |
For institutional investors. Book with your work email.
A28 Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 33% MoM.
- Nov 7, 2025
Monthly visitors increased 166% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
A28 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about A28 Therapeutics's valuation, stock price, and market status.
Is A28 Therapeutics a public or private company?
A28 Therapeutics is a private company.
What is the current stock price of A28 Therapeutics?
A28 Therapeutics is a private company, so its shares have no public market price. Caplight tracks A28 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is A28 Therapeutics worth (valuation)?
Valuation information for A28 Therapeutics is not publicly available.
Can I buy A28 Therapeutics stock?
A28 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was A28 Therapeutics's last funding round?
A28 Therapeutics's most recent funding round was Series A on October 30, 2023.
Who are the main investors in A28 Therapeutics?
Investor information for A28 Therapeutics is not publicly disclosed.
Will A28 Therapeutics IPO soon?
No public IPO plans have been announced for A28 Therapeutics.
How can I track A28 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in A28 Therapeutics's shares on secondary markets.